How fibroblast/hormone interactions affect endometrial function
A genome-wide analysis sheds light on how hormone response in endometrial cells affects endometrial function.
The endometrium is a dynamic tissue that undergoes dynamic cyclic proliferation and differentiation to prepare for pregnancy. Endometrial stromal fibroblasts (eSFs) are key regulators of pregnancy success.
How the cells interact with circulating levels of ovarian-derived estradiol (E2) and progesterone (P4) is unknown. Results of a new genome-wide analysis suggest that the complex interplay between eSFs, E2 and P4 has a significant impact on endometrial function or dysfunction1.
To further understand the dynamic interactions, a team of researchers studied the effects of E2, P4, and their combination (E2+P4) on the DNA methylome and transcriptome and their interplay in normal eSF.
The effects on the cells were analyzed at 14 days of exposure to the hormones, mimicking the timeframe of a typical menstrual cycle.
The cells used in the study were derived from women with and without endometriosis. Those without the disease and who had no known gynecologic or systemic disorders served as the study’s control group.
Researchers only included endometrial samples from extensively screened volunteers without any gynecologic disorders and no uterine pathology (NUP), with confirmed in vitro eSF progesterone responsiveness.
The researchers investigated 485,577 methylation targets across the genome and found that E2 and P4 alone and in combination affected the DNA methylome to varying extents and with distinct patterns in eSF.
Related: Impact of endometrial thickness and abnormal uterine bleeding on endometrial cancer
The study also showed that hormone-DNA methylome dynamics differ under normal and disease conditions, and that the stage of endometriosis affects the hormone-methylome response. The most blunted response to the hormones was seen in cells from women with advanced endometriosis.
Novel responses to E2 that had not reported before were seen in eSFs from women with the disease. The different aberrant DNA methylation signatures in eSFs from the group with endometriosis suggest that there are distinct subtypes of the disease.
__
Reference
- Houshdaran S, Oke AB, Fung JC, et al. Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis. PLoS Genet. 2020;16(6):e1008601. Published 2020 Jun 17. doi:10.1371/journal.pgen.1008601
__
Image credit: By Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=18158244
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
